SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Netflix has not officially confirmed Black Mirror Season 8. However, creator Charlie Brooker has expressed his commitment to ...

D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT. All of our product candidates are in clinical or preclinical development and have not yet ...

Despite challenges from market uncertainty and the potential impacts of tariffs, executives from Bay Area startups Abridge, ...

Under the terms of the agreement, Oncolytics has the right to sell, and Alumni has the obligation to purchase up to US$20 ...

We shouldn’t be celebrating “de-extinction.” We should be focused on the species that are currently in danger.

Researchers examine the impact of AI-based personalized nutrition programs on the gut microbiome of healthy individuals.

Portuguese biotech FairJourney Biologics has acquired South San Francisco antibody R&D facility from Charles River Labs, ...

NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced promising new findings from its ...

“The de-extinction of the dire wolf and an end-to-end system for de-extinction is transformative and heralds an entirely new ...